Tai Chi and eCB in Women
TC-eCB
Tai Chi and eCB in Postmenopausal Women
1 other identifier
interventional
18
1 country
1
Brief Summary
The endocannabinoid system (ECS) is widely found in central and peripheral systems, and the immune system. Moderate-intensity aerobic exercise has shown to increase circulatory endocannabinoids. In this study, we will study Tai Chi, a mind-body moderate-intensity exercise, intervention for its effects on ECS in women. A pre-post design trial will be conducted on 18 qualified subjects. We will measure plasma eCB levels at baseline, before and after 4th session of Tai Chi. All data will be analyzed statistically at p\<0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Aug 2019
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2019
CompletedFirst Posted
Study publicly available on registry
January 30, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedApril 2, 2025
March 1, 2025
5 years
January 28, 2019
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
plasma eCB level
AEA and 2-AG
1 week
Study Arms (1)
Tai Chi
EXPERIMENTALTai Chi exercise
Interventions
Eligibility Criteria
You may qualify if:
- Postmenopausal women (menopause is defined as the absence of menstrual period for 12 months, not related to pregnancy/lactation, hormonal contraception). Age 40-70 years old with BMI between 25-35 kg/m2.
- English literacy.
You may not qualify if:
- prior experience with mind-body practice (e.g., TC, Qi Gong, yoga, meditation).
- Severe medical limitations (i.e., dementia, symptomatic heart or vascular disease, or recent stroke) precluding full participation.
- Medical/neurologic or other systemic diseases affecting the musculoskeletal systems (i.e. polio/Parkinson's/ multiple sclerosis, etc. in addition to cerebral vascular accident or stroke) and diabetes with peripheral neuropathy affecting their sensory/balance.
- taking pain/anti-inflammatory and sleep medications within the 3 months before study starts.
- taking hormone-replacement therapy within the 3 months before study starts.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Tech University Health Sciences Center
Lubbock, Texas, 79430, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chwan-li Shen, PhD
Texas Tech University Health Sciences Center
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2019
First Posted
January 30, 2019
Study Start
August 1, 2019
Primary Completion
July 31, 2024
Study Completion
October 31, 2024
Last Updated
April 2, 2025
Record last verified: 2025-03